Active

IMMUNO-CELL INTERNATIONAL

Switched

BE0453361865

Rechtspersoon Private limited company 2 establishments

Motstraat 72, 2800 Mechelen Vervaardiging van holglas

Active for

32 year, 1 month

Financials

Financial year 2025

Gross margin

€ 975,426

▼ 12% vs 2024

Profit

Healthy

€ 478,283

▼ 8% vs 2024

Debts

Low

€ 604,085

▲ 6% vs 2024

IMMUNO-CELL INTERNATIONAL from Mechelen, company number BE0453361865, closed financial year 2025 with a result of € 478,283 after tax. For that financial year IMMUNO-CELL INTERNATIONAL recorded a gross margin of € 975,426 and equity of € 955,309. Compared with financial year 2024, the result moved from € 521,820 to € 478,283. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 8, 2026.

What happened at IMMUNO-CELL INTERNATIONAL?

What happened at IMMUNO-CELL INTERNATIONAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 478,283 (▼ 8% vs 2024). Source: NBB ↗
  • New establishment in Mechelen. KBO
  • New establishment in Mechelen. KBO
  • Start of the company according to the CBE. KBO

In short

From € 476,999 profit in 2021 to € 478,283 profit in 2025.

Paid € 854,008 in corporate taxes since 2021.

Best year ever: 2022, with € 563,640 profit.

On average € 150,100 of value added per employee in 2025.

A new publication or filing at IMMUNO-CELL INTERNATIONAL? We notify you, reason included.

Follow IMMUNO-CELL INTERNATIONAL

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Quentin Speeckaert
James Dehé
IMMUNO-CELL INTERNATIONAL

Behind IMMUNO-CELL INTERNATIONAL are Quentin Speeckaert and James Dehé. The same people are also behind EXETERA and Orexys.

See the full network in the app

Directors

According to the 2025 annual accounts

Quentin Speeckaert

Director

Also active at: EXETERA, Orexys

James Dehé

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Motstraat 72 box 8

2800 Mechelen

2.313.640.139

Motstraat 72 box 9

2800 Mechelen

Active since 1 February 2021

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0453.361.865
VAT number
BE 0453.361.865
Registered office
Motstraat 72 bus 8, 2800 Mechelen
Names & denominations
IMMUNO-CELL INTERNATIONAL
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
1 August 1994
Peppol
Active · Active since 1 Jan 2001
Activities · NACE

Vervaardiging van holglas

Overige activiteiten op het gebied van drukwerk

Overige drukkerijen

Groothandel in farmaceutische en medische artikelen

Overige detailhandel in nieuwe artikelen neg

Overige gespecialiseerde detailhandel in artikelen, andere dan voedingsmiddelen, n.e.g.

Groothandel in farmaceutische producten

Frequently asked questions

What is the enterprise number of IMMUNO-CELL INTERNATIONAL?
The enterprise number of IMMUNO-CELL INTERNATIONAL is BE0453361865.
What is the address of IMMUNO-CELL INTERNATIONAL?
The registered office of IMMUNO-CELL INTERNATIONAL is located at Motstraat 72 box 8, 2800 Mechelen.
When was IMMUNO-CELL INTERNATIONAL founded?
IMMUNO-CELL INTERNATIONAL was founded on 1 August 1994.
What is the main activity of IMMUNO-CELL INTERNATIONAL?
The main activity of IMMUNO-CELL INTERNATIONAL is "Vervaardiging van holglas" (NACE code 23130).
Does IMMUNO-CELL INTERNATIONAL have a website?
No website is currently known for IMMUNO-CELL INTERNATIONAL.
How much profit did IMMUNO-CELL INTERNATIONAL make in 2025?
IMMUNO-CELL INTERNATIONAL posted a profit after taxes of € 478,283 in financial year 2025.
What is the revenue of IMMUNO-CELL INTERNATIONAL?
As a small company, IMMUNO-CELL INTERNATIONAL is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 975,426.
How many employees does IMMUNO-CELL INTERNATIONAL have?
According to the 2025 annual accounts, IMMUNO-CELL INTERNATIONAL has 6.5 full-time equivalents (FTE).
Where can I find the annual accounts of IMMUNO-CELL INTERNATIONAL?
IMMUNO-CELL INTERNATIONAL files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of IMMUNO-CELL INTERNATIONAL?
According to the 2025 annual accounts, the directors of IMMUNO-CELL INTERNATIONAL are: Quentin Speeckaert, James Dehé.
Who owns IMMUNO-CELL INTERNATIONAL?
Behind IMMUNO-CELL INTERNATIONAL are Quentin Speeckaert and James Dehé. The same people are also behind EXETERA and Orexys.